See more : Wai Yuen Tong Medicine Holdings Limited (0897.HK) Income Statement Analysis – Financial Results
Complete financial analysis of U.S. Physical Therapy, Inc. (USPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of U.S. Physical Therapy, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Corus Entertainment Inc. (CJR-B.TO) Income Statement Analysis – Financial Results
- Corteva, Inc. (CTVA) Income Statement Analysis – Financial Results
- Mach7 Technologies Limited (M7T.AX) Income Statement Analysis – Financial Results
- Soligenix, Inc. (SNGX) Income Statement Analysis – Financial Results
- Incannex Healthcare Limited (IXHL) Income Statement Analysis – Financial Results
U.S. Physical Therapy, Inc. (USPH)
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 604.80M | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M | 414.05M | 356.55M | 331.30M | 305.07M | 264.06M | 252.09M | 237.01M | 211.23M | 201.41M | 187.69M | 151.69M | 135.19M | 132.12M | 118.31M | 105.57M | 94.74M | 80.95M | 63.22M | 49.94M | 44.00M | 38.80M | 32.20M | 24.90M | 17.20M | 8.40M | 2.40M | 600.00K |
| Cost of Revenue | 492.82M | 441.12M | 377.84M | 328.52M | 369.50M | 352.25M | 323.43M | 274.53M | 252.94M | 228.91M | 199.36M | 189.50M | 172.51M | 151.82M | 146.24M | 140.08M | 114.33M | 99.35M | 96.21M | 85.28M | 74.60M | 64.53M | 54.88M | 42.90M | 34.09M | 30.80M | 27.30M | 22.10M | 17.40M | 13.20M | 6.20M | 1.70M | 500.00K |
| Gross Profit | 111.99M | 112.02M | 117.18M | 94.45M | 112.47M | 101.66M | 90.62M | 82.01M | 78.36M | 76.17M | 64.70M | 62.59M | 64.49M | 59.42M | 55.17M | 47.60M | 37.36M | 35.84M | 35.91M | 33.03M | 30.96M | 30.21M | 26.07M | 20.32M | 15.84M | 13.20M | 11.50M | 10.10M | 7.50M | 4.00M | 2.20M | 700.00K | 100.00K |
| Gross Profit Ratio | 18.52% | 20.25% | 23.67% | 22.33% | 23.34% | 22.40% | 21.89% | 23.00% | 23.65% | 24.97% | 24.50% | 24.83% | 27.21% | 28.13% | 27.39% | 25.36% | 24.63% | 26.51% | 27.18% | 27.92% | 29.33% | 31.89% | 32.20% | 32.14% | 31.73% | 30.00% | 29.64% | 31.37% | 30.12% | 23.26% | 26.19% | 29.17% | 16.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 51.95M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -9.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.43M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 4.20M | 4.50M | 3.50M | 1.70M | 400.00K |
| Other Expenses | 0.00 | 859.00K | -4.60M | -13.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.79M | 3.24M | 3.35M | 0.00 | 0.00 | 0.00 | 604.00K | 238.00K | 0.00 | 0.00 | 0.00 | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| Operating Expenses | 42.43M | 46.11M | 41.94M | 28.54M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 28.56M | 26.23M | 26.74M | 23.73M | 17.33M | 17.25M | 17.03M | 17.04M | 13.97M | 11.33M | 9.12M | 9.94M | 8.58M | 7.70M | 6.70M | 6.50M | 5.90M | 5.80M | 4.10M | 1.90M | 400.00K |
| Cost & Expenses | 535.25M | 487.23M | 419.78M | 357.06M | 414.54M | 393.60M | 359.32M | 307.01M | 284.01M | 259.31M | 225.29M | 214.29M | 201.08M | 178.04M | 172.98M | 163.81M | 131.65M | 116.60M | 113.24M | 102.32M | 88.57M | 75.87M | 64.00M | 52.84M | 42.67M | 38.50M | 34.00M | 28.60M | 23.30M | 19.00M | 10.30M | 3.60M | 900.00K |
| Interest Income | 3.77M | 859.00K | 199.00K | 142.00K | 46.00K | 93.00K | 88.00K | 93.00K | 81.00K | 18.00K | 7.00K | 6.00K | 5.45M | 586.00K | 8.00K | 260.00K | 273.00K | 332.00K | 361.00K | 146.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.30M | 5.78M | 942.00K | 1.63M | 2.08M | 2.04M | 21.06M | 11.48M | 1.03M | 1.09M | 538.00K | 557.00K | 496.00K | 236.00K | 352.00K | 542.00K | 301.00K | 0.00 | 361.00K | 0.00 | 189.00K | 214.00K | 266.00K | 780.00K | 727.00K | 700.00K | 0.00 | 700.00K | 700.00K | 600.00K | 200.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 15.70M | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M | 9.71M | 8.78M | 7.95M | 6.74M | 5.56M | 5.29M | 5.45M | 5.67M | 5.90M | 5.97M | 4.99M | 4.49M | 4.31M | 4.32M | 3.59M | 2.96M | 2.57M | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| EBITDA | 74.37M | 76.09M | 85.73M | 77.68M | 83.08M | 72.01M | 64.53M | 58.41M | 55.33M | 52.53M | 44.34M | 43.10M | 46.83M | 39.44M | 34.16M | 30.10M | 25.02M | 23.09M | 24.84M | 20.83M | 20.59M | 21.83M | 19.51M | 12.72M | 9.36M | 7.60M | 6.70M | 5.30M | 3.30M | -500.00K | -1.30M | -1.00M | -300.00K |
| EBITDA Ratio | 12.30% | 14.95% | 17.85% | 18.11% | 17.24% | 15.46% | 15.58% | 16.38% | 16.70% | 17.22% | 16.79% | 17.10% | 19.76% | 18.67% | 17.05% | 15.90% | 16.50% | 17.08% | 18.01% | 17.37% | 19.50% | 23.04% | 24.11% | 20.11% | 18.74% | 17.73% | 17.27% | 16.46% | 12.05% | -2.91% | -15.48% | -41.67% | -50.00% |
| Operating Income | 69.56M | 56.80M | 76.77M | 52.41M | 67.43M | 60.31M | 54.73M | 49.53M | 47.29M | 45.77M | 38.77M | 37.80M | 35.93M | 33.19M | 28.43M | 23.88M | 20.04M | 18.60M | 18.88M | 15.99M | 17.00M | 18.87M | 16.95M | 10.38M | 7.27M | 5.50M | 4.80M | 3.60M | 1.60M | -1.80M | -1.90M | -1.20M | -300.00K |
| Operating Income Ratio | 11.50% | 10.27% | 15.51% | 12.39% | 13.99% | 13.29% | 13.22% | 13.89% | 14.28% | 15.00% | 14.68% | 15.00% | 15.16% | 15.71% | 14.11% | 12.72% | 13.21% | 13.76% | 14.29% | 13.52% | 16.10% | 19.92% | 20.94% | 16.42% | 14.55% | 12.50% | 12.37% | 11.18% | 6.43% | -10.47% | -22.62% | -50.00% | -50.00% |
| Total Other Income/Expenses | -20.18M | -1.23M | 2.55M | 13.10M | 3.48M | -103.00K | -20.97M | -11.39M | -7.16M | -1.07M | -531.00K | 52.00K | 446.00K | 350.00K | -344.00K | -282.00K | -5.76M | -5.35M | -5.61M | -366.00K | -5.16M | -5.06M | -5.45M | -4.25M | -3.30M | -2.80M | -2.30M | -1.90M | 300.00K | 0.00 | 0.00 | 0.00 | 300.00K |
| Income Before Tax | 49.38M | 55.57M | 73.20M | 65.51M | 70.91M | 60.21M | 33.76M | 38.15M | 46.34M | 44.70M | 38.24M | 37.25M | 40.88M | 33.54M | 28.08M | 16.51M | 14.28M | 13.25M | 14.30M | 10.78M | 11.78M | 13.72M | 11.50M | 6.14M | 3.96M | 2.70M | 2.50M | 1.70M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 8.16% | 10.05% | 14.79% | 15.49% | 14.71% | 13.26% | 8.15% | 10.70% | 13.99% | 14.65% | 14.48% | 14.78% | 17.25% | 15.88% | 13.94% | 8.80% | 9.41% | 9.80% | 10.82% | 9.11% | 11.16% | 14.49% | 14.21% | 9.71% | 7.93% | 6.14% | 6.44% | 5.28% | 7.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 12.16M | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M | 6.03M | 11.88M | 14.65M | 14.27M | 12.24M | 11.03M | 11.10M | 8.84M | 8.11M | 6.51M | 5.47M | 5.06M | 5.51M | 4.10M | 4.45M | 5.24M | 4.43M | 2.40M | 1.57M | 1.10M | 100.00K | 100.00K | 900.00K | 1.00M | 300.00K | 0.00 | 200.00K |
| Net Income | 14.67M | 43.41M | 57.92M | 52.49M | 57.26M | 10.10M | 22.26M | 20.55M | 22.28M | 19.77M | 12.72M | 17.93M | 20.97M | 15.65M | 11.77M | 10.00M | 8.89M | 6.30M | 8.79M | 6.68M | 7.33M | 8.49M | 7.07M | 3.74M | 2.39M | 1.60M | 2.40M | 1.60M | 700.00K | -2.80M | -2.20M | -1.20M | -200.00K |
| Net Income Ratio | 2.43% | 7.85% | 11.70% | 12.41% | 11.88% | 2.23% | 5.38% | 5.76% | 6.72% | 6.48% | 4.82% | 7.11% | 8.85% | 7.41% | 5.84% | 5.33% | 5.86% | 4.66% | 6.65% | 5.64% | 6.94% | 8.96% | 8.74% | 5.91% | 4.79% | 3.64% | 6.19% | 4.97% | 2.81% | -16.28% | -26.19% | -50.00% | -33.33% |
| EPS | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.52 | 1.78 | 1.34 | 1.01 | 0.84 | 0.75 | 0.54 | 0.74 | 0.56 | 0.66 | 0.77 | 0.70 | 0.13 | 0.12 | 0.05 | 0.08 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| EPS Diluted | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.51 | 1.75 | 1.32 | 1.00 | 0.83 | 0.75 | 0.54 | 0.73 | 0.54 | 0.61 | 0.67 | 0.55 | 0.11 | 0.11 | 0.05 | 0.07 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| Weighted Avg Shares Out | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.06M | 11.80M | 11.81M | 11.64M | 11.70M | 11.91M | 11.64M | 11.69M | 11.92M | 11.93M | 11.11M | 11.02M | 10.10M | 9.56M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
| Weighted Avg Shares Out (Dil) | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.08M | 11.90M | 11.98M | 11.87M | 11.81M | 12.06M | 11.72M | 11.69M | 12.04M | 12.37M | 12.02M | 12.67M | 12.86M | 10.70M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
U.S. Physical Therapy (USPH) Beats Q2 Earnings and Revenue Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.90 per share a year ago.
U.S. Physical Therapy Reports Second Quarter 2023 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and six months ended June 30, 2023. SECOND...
U.S. Physical Therapy Announces Acquisition of a Five-Clinic Physical Therapy Practice
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced an acquisition of a physical therapy practice with five clinics. USPH acquired...
U.S. Physical Therapy, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call Dates
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2023...
OPCH or USPH: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their...
U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
U.S. Physical Therapy has shown significant potential for capital appreciation, based on asset factors and earnings power. Its latest numbers showed record high clinics combined with attractive profitability numbers. Following a revision to estimates, USPH presents with a potential equity...
U.S. Physical Therapy to Present at the CJS Securities 23rd Annual New Ideas Summer Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (the “Company”), today announced that Carey Hendrickson, the Company's Chief Financial Officer, will present at the CJS Securities...
U.S. Physical Therapy (USPH) Surges 3.7%: Is This an Indication of Further Gains?
U.S. Physical Therapy (USPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
U.S. Physical Therapy Announces Acquisition of a Four-Clinic Physical Therapy Practice
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced an acquisition of a physical therapy practice with four clinics. USPH and...
Source: https://incomestatements.info
Category: Stock Reports